Trial intelligence / Profile preview

Assessment of the effects of pressors on graft blood flow after free tissue transfer surgery

2008-000073-37Phase 4Completed

Sponsor
Oxford University Hospitals
Start
Oct 2008
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of dopexamine, dobutamine, epinephrine and norepinephrine in None, mouth cancer and maxillofacial injuries (MFT) (4 arms), sponsored by Oxford University Hospitals. Primary endpoints: Optimal pharmacological agent for blood pressure maintenance, Absolute change in flap vascular resistance after pressor infusion and 1 more. Started Oct 2008; status: completed.

02

Drugs

dopexaminedobutamineepinephrinenorepinephrine
03

Conditions

mouth cancermaxillofacial injuries (MFT)

Beyond the preview

Go deeper on 2008-000073-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-000073-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call